Back
Speaker illustration

Professor John Atherton

Royal Brisbane and Women's Hospital, Brisbane (Australia)

Member of:

European Society of Cardiology
Heart Failure Association

John Atherton is Director of Cardiology (Royal Brisbane and Women’s Hospital), Professor (University of Queensland), Adjunct Professor (Queensland University of Technology) and Pre-eminent Staff Specialist (Queensland Health). He was one of four non-European official content reviewers for the 2016 ESC Heart Failure Guidelines and chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines. He previously chaired the Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Council and the Asia-Pacific Acute Decompensated Heart Failure Registry Scientific Advisory Committee. He is the Queensland Cardiac Outcomes Registry- Heart Failure Data Custodian (enrolls over 6,000 patients/ year). Research interests include biomarker evaluation, heart failure disease management and cardiac genetics.

Sessions Presentations

Chronic heart failure and atrial fibrillation

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Moderated ePosters

Access
Thumbnail

Controversies in 2021 OMT: should SGLT2i and ARNI now be considered first line treatments in HFrEF?

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session type: Debate Session

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb